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Acute Ischaemic Stroke: A Case-Controlled Multicentre Registry Study
Rathenborg L.K., Venermo M., Troëng T., Jensen L.P., Vikatmaa P.,
Wahlgren C., Ijäs P., Björck M., Kragsterman B. Eur J Vasc Endovasc
Surg 2014;48:620-5.
Objective: Few studies have been published on the safety of carotid
endarterectomy (CEA) after intravenous thrombolysis (IVT). Registry re-
ports have been recommended in order to gather large study groups.
Design: A retrospective, registry based, case controlled study on pro-
spectively gathered data from Sweden, the capital region of Finland, and
from Denmark, including 30 days of follow up.
Methods: The study group was a consecutive series of 5526 patients
who had CEA for symptomatic carotid artery stenosis during a 4.5 year
period. Among these, 202 (4%) had IVT prior to surgery, including 117
having CEA within 14 days, and 59 within 7 days of thrombolysis. IVT
as well as CEA were performed following established guidelines. The me-
dian time from index symptom to CEA was 12 days (range 0e130, IQR
7e21).
Results: The 30 day combined stroke and death rate was 3.5% (95%
CI 1.69e6.99) for those having IVT + CEA, 4.1% (95% CI 3.46e4.39)
for those having CEA without previous IVT (odds ratio 0.84 [95% CI
0.39e1.81]), 3.4% (95% CI 1.33e8.39) for those having IVT + CEA
within 14 days, and 5.1% (95% CI 1.74e13.91) for those having IVT +
CEA within 7 days.
Conclusion: Data on the time from symptoms to CEA in patients not
having IVT, Rankin score, degree of stenosis, and cerebral imaging were not
available. Despite its weaknesses, this study reasserts that CEA can be per-
formed within the recommended 2 weeks of the onset of symptoms and
IVT without increasing the risk of peri-operative stroke or death. Centres
and vascular registries are recommended to continue monitoring changes
in patient characteristics, lead times, and major complications after CEA
in general, with a special focus on those who have undergone a prior
thrombolysis.
Outcomes of Fenestrated/Branched Endografting in Post-dissection
Thoracoabdominal Aortic Aneurysms
Oikonomou K., Kopp R., Katsargyris A., Pﬁster K., Verhoeven E.L.,
Kasprzak P. Eur J Vasc Endovasc Surg 2014;48:641-8.
Objectives: Fenestrated/branched thoracic endovascular repair (F/
Br-TEVAR) is increasingly applied for atherosclerotic thoracoabdominal
aortic aneurysm (TAAA); however, use in post-dissection TAAAs is still
very limited. Experience with F/Br-TEVAR in the treatment of post-dissec-
tion TAAA is presented.
Methods: Data were analysed from prospectively maintained data-
bases including all patients with post-dissection TAAAs that underwent
F/Br-TEVAR within the period January 2010 to July 2013 in two vascular
institutions. Evaluated outcomes included initial technical success, operative
mortality and morbidity, late survival, endoleak, aneurysm diameter regres-
sion, renal function, and reintervention during follow-up (FU).
Results: A total of 31 patients (25 male, mean age 65 6 11.4 years)
were treated. Technical success was 93.5% and 30-day mortality 9.6%. Tem-
porary spinal cord ischaemia occurred in four (12.6%) patients, with no case
of permanent paraplegia. Mean FU was 17.0 6 10 months. There were
seven late deaths, all aneurysm unrelated. Estimated overall survival rates
were 83.9 6 6.7, 76.4 6 7.9 and 71.6 6 8.7% at 6, 12, and 18 months,
respectively. Impairment of renal function occurred in two (6.4%) patients.
Endoleaks were diagnosed in 12 patients during FU, including six type IB
endoleaks and six type II endoleaks. Reintervention was required in seven
(22.5%) patients. Mean aneurysm sac regression was 9.3 6 8.7 mm, with
a false lumen thrombosis rate of 66.7% and 88.2% for patients with a FU
longer than 6 and 12 months respectively.
Conclusions: F/Br-EVAR is feasible for patients with a post-dissec-
tion TAAA. Although associated with additional technical challenges, and
a signiﬁcant need for reintervention, it leads to favourable aneurysm1712morphologic changes, and may play a more prominent role in the future
for this type of pathology if long-term results conﬁrm the good initial
outcome.
Low Post-operative Mortality after Surgery on Patients with
Screening-detected Abdominal Aortic Aneurysms: A Swedvasc
Registry Study
Linné A., Smidfelt K., Langenskiöld M., Hultgren R., Nordanstig J.,
Kragsterman B., Lindström D. Eur J Vasc Endovasc Surg 2014;48:649-56.
Objectives: Screening for abdominal aortic aneurysms (AAAs) sub-
stantially reduces aneurysm-related mortality in men and is increasing
worldwide. This cohort study compares post-operative mortality and com-
plications in men with screening-detected vs. non-screening-detected AAAs.
Methods: Data were extracted from the Swedish National Registry
for Vascular Surgery (Swedvasc) for all screening-detected men treated for
AAA (n = 350) and age-matched controls treated for non-screening-
detected AAA (n = 350).
Results: There were no differences in baseline characteristics besides
age, which was lower in the screening-detected group than in the non-
screening-detected group (median 66 vs. 68, p < .001). Open repair was
used more frequently than endovascular aortic repair (EVAR) in patients
with screening-detected AAAs than in non-screening-detected controls
(56% vs. 45% p = .005). No differences in major post-operative complica-
tions at 30 days were observed between the groups. In patients treated
with open repair there were no differences in 30-day, 90-day or 1-year mor-
tality in screening-detected patients compared to non-screening-detected
controls (1.0% vs. 3.2% p = .25, 2.1% vs. 4.5% p = .23, 4.1% vs. 5.8% p =
.61). None of the patients treated with EVAR in either group died within
30 days. The 90-day mortality after EVAR was lower in patients with
screening-detected AAA than in those with non-screening-detected AAAs
(0.0% vs. 3.1%, p = .04). No difference in the 1-year mortality was detected
in the EVAR-patients between the two groups (1.4% vs. 4.7%, p = .12).
Conclusions: The contemporary post-operative mortality after AAA
surgery was low in this national audit of patients with screening-detected
AAAs and age-matched controls. Patients with screening-detected AAAs
have the same frequency of complications at 30 days as patients with non-
screening-detected AAA. This study gives further support to national
screening programs for the detection of AAA in men.
Abdominal Aortic Diameter Is Increased in Males with a Family
History of Abdominal Aortic Aneurysms: Results from the Danish
VIVA-trial
Joergensen T.M.M., Houlind K., Green A., Lindholt J.S. Eur J Vasc
Endovasc Surg 2014;48:669-75.
Objective: To investigate, at a population level, whether a family his-
tory of abdominal aortic aneurysm (AAA) is independently related to
increased aortic diameter and prevalence of AAA in men, and to elucidate
whether the mean aortic diameter and the prevalence of AAA are different
between participants with male and female relatives with AAA.
Design: Observational population-based cross-sectional study.
Materials: 18,614 male participants screened for AAA in the VIVA-
trial 2008 e2011 with information on both family history of AAA and
maximal aortic diameter.
Methods: Standardized ultrasound scan measurement of maximum
antero-posterior aortic diameter. Family history obtained by questionnaire.
Multivariate regression analysis was used to test for confounders: age, sex,
smoking, comorbidity and medication.
Results: From the screened cohort, 569 participants had at least one
ﬁrst degree relative diagnosed with AAA, and 38 had AAA. Participants with
a family history of AAA (+FH) had a signiﬁcantly larger mean maximum
aortic diameter (20.50 mm) compared with participants without family
history of AAA (FH) (19.07 mm, p < .0001), and +FH with female rel-
atives with AAA had signiﬁcantly larger mean maximum aortic diameter
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the prevalence of AAA was signiﬁcantly higher among +FH (6.7%)
compared with FH (3.0%) with an odds ratio (OR) of 2.2 (95% CI: 1.6
to 3.2, p < .001) and +FH with female relatives with AAA had a more
than two and a half times increased prevalence of AAA compared with
+FH with male relatives with AAA with an OR of 2.65.
Conclusions: First-degree male relatives of AAA patients have wider
aortas and a twofold higher prevalence of AAA compared with the age
adjusted background population. The prevalence of AAA was markedly
higher in participants related to female, rather than male, patients with AAA.
Abdominal Aortic Aneurysms with High Thrombus Signal Intensity
on Magnetic Resonance Imaging are Associated with High Growth
Rate
Nguyen V.L., Leiner T., Hellenthal F.A.M.V.I., Backes W.H.,
Wishaupt M.C.J., van der Geest R.J., Heeneman S., Kooi M.E.,
Schurink G.W.H. Eur J Vasc Endovasc Surg 2014;48:676-84.
Objectives: A layer of intraluminal thrombus is commonly observed
in abdominal aortic aneurysms (AAAs). The purpose of this study was to
investigate whether AAAs with high thrombus signal intensity (SI) at T1-
weighted (T1w) magnetic resonance imaging (MRI) exhibit a faster aneu-
rysm growth rate.
Methods: This was a prospective follow-up study. Patients with a
small AAA underwent MRI examinations at 6 month intervals. Aneurysm
thrombus and psoas muscle SI at the point of maximal diameter on T1w im-
ages were measured and expressed as a ratio (thrombus SI/muscle SI).
Based on these measurements, patients were categorized into three groups:
AAA with relative thrombus SI above (group A) and below (group B) the
mean relative thrombus SI of 1.20. Patients with AAA without thrombus
constituted group C. Eight patients were scanned twice within 2 weeks to
investigate scanerescan reproducibility. Aneurysm growth rates were
expressed as the change in maximal cross sectional area (cm2).
Results: A total of 35 patients (m/f: 26/9; age 72 6 7 years; AAA
maximal diameter 4.9 6 0.5 cm) were included. Mean aneurysm growth
rate for patients in group A (n ¼ 11, 1.87 cm2/0.5 year) was two-fold
higher than group B (n ¼ 17, 0.78 cm2/0.5 year, p ¼ .005) and eight-
fold higher than group C (n ¼ 7, 0.23 cm2/0.5 years, p ¼ .004) at 6
months’ follow-up. At 12 months’ follow-up, the mean aneurysm growth
rate remained signiﬁcantly higher in group A (n ¼ 7, 3.03 cm2/year)than groups B (n ¼ 10, 1.63 cm2/year, p ¼ .03) and C (n ¼ 7, 0.73
cm2/year, p ¼ .004). The reproducibility for thrombus SI measurements
was found to be high with a coefﬁcient of variation of 6.2%. Aneurysm
maximal cross-sectional area at baseline was not signiﬁcantly different for
the three groups.
Conclusions: Abdominal aortic aneurysms with high thrombus SI on
T1w MR images are associated with higher aneurysm growth rates.
Association Between Salivary Cotinine and Cardiovascular Biomarkers
Among Nonsmokers and Current Smokers: Cross-sectional Study of
10,081 Participants
Lu L., Mackay D.F., Newby D.E., Pell J.P. Eur J Vasc Endovasc Surg
2014;48:703-10.
Objective: Both active smoking and exposure to secondhand smoke
(SHS) are associated with cardiovascular disease, but sidestream smoke con-
tains higher levels of small particles and toxic gases than mainstream smoke.
The relationship between the concentration of cotinine and a number of car-
diovascular biomarkers among nonsmokers and active smokerswas examined.
Methods: A cross-sectional study using the Scottish Health Surveys
conducted between 1998 and 2010 was undertaken. Inclusion was
restricted to participants aged $16 years who had provided saliva and blood
samples. Uni- and multivariate regression models were used to examine the
relationships between the concentration of cotinine and C-reactive protein
(CRP), high-density lipoprotein (HDL) cholesterol, and ﬁbrinogen concen-
trations, as well as total:HDL cholesterol ratios.
Results: Of the 10,018 eligible participants, 7,345 (73.3%) were
conﬁrmed to be nonsmokers (cotinine <15.0 ng/mL) and 2,673 (26.7%)
were conﬁrmed to be current smokers (cotinine $15.0 ng/mL). CRP
and total:HDL cholesterol increased, and HDL cholesterol decreased,
with increasing cotinine concentration across nonsmokers and smokers
(all p < .001). However, there were step changes at the interface, whereby
nonsmokers with a high exposure to SHS had lower concentrations of co-
tinine than light active smokers but comparable concentrations of CRP
(p ¼ .709), HDL cholesterol (p ¼ .931), and total:HDL cholesterol (p ¼
.405). Fibrinogen concentrations were signiﬁcantly raised in moderate
and heavy active smokers only (both p < .001).
Conclusion: Exposure to SHS is associated with disproportionately
higher biomarkers of cardiovascular risk compared with active smoking.
Protection from exposure to SHS should be a public health priority.
